(Q36388079)

13 August 2017

Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic study (English)

1 reference

13 August 2017

1 reference

1 reference

1 reference

1 reference

8

J H Beijnen

1 reference

13 August 2017

M Joerger

1

1 reference

13 August 2017

A D R Huitema

2

1 reference

13 August 2017

M T Huizing

3

1 reference

13 August 2017

P H B Willemse

4

1 reference

13 August 2017

A de Graeff

5

1 reference

13 August 2017

H Rosing

6

1 reference

13 August 2017

J H M Schellens

7

1 reference

13 August 2017

J B Vermorken

9

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

British Journal of Clinical Pharmacology

13 August 2017

1 reference

13 August 2017

64

1 reference

13 August 2017

5

1 reference

13 August 2017

622-633

1 reference

Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203269

Inter-relationships of paclitaxel disposition, infusion duration and cremophor EL kinetics in cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203269

Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203269

Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203269

Hepatic metabolism of paclitaxel and its impact in patients with altered hepatic function

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203269

Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients

28 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02956.X

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02956.X

Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02956.X

Model of chemotherapy-induced myelosuppression with parameter consistency across drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02956.X

Mechanism-based pharmacokinetic model for paclitaxel

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203269

Pharmacokinetics of paclitaxel and three major metabolites in patients with advanced breast carcinoma refractory to anthracycline therapy treated with a 3-hour paclitaxel infusion: a European Cancer Centre (ECC) trial.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203269

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2203269

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients

21 September 2018

1 reference

12 December 2020

High-performance liquid chromatographic procedure for the quantitative determination of paclitaxel (Taxol) in human plasma

1 reference

12 December 2020

Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors

1 reference

12 December 2020

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

12 December 2020

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans

1 reference

12 December 2020

Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL

1 reference

12 December 2020

Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography

1 reference

12 December 2020

Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre

1 reference

12 December 2020

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

12 December 2020

10.1111/J.1365-2125.2007.02956.X

Identifiers

DOI

1 reference

release_eoejgbznhze2pgwmeswwidngkq

13 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eoejgbznhze2pgwmeswwidngkq

24 November 2022

mapped directly with Wikidata item

1 reference

13 August 2017

PubMed publication ID

17935602

1 reference